Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer's disease.

Calvo-Rodriguez M, Hou SS, Snyder AC, Kharitonova EK, Russ AN, Das S, Fan Z, Muzikansky A, Garcia-Alloza M, Serrano-Pozo A, Hudry E, Bacskai BJ. · 2020

Read Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer's disease. by Calvo-Rodriguez M, Hou SS, Snyder AC, Kharitonova EK, Russ AN, Das S, Fan Z, Muzikansky A, Garcia-Alloza M, Serrano-Pozo A, Hudry E, Bacskai BJ. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7195480.txt.

Introduction

Calvo-Rodriguez and co-authors measure calcium inside mitochondria of brain cells in a mouse model of Alzheimer's disease. Their study appeared in Nature Communications. Mitochondria help shape calcium signals inside neurons. Too much calcium taken up can kill the cell. Amyloid beta, the protein that builds plaques, overloads cells with calcium.

Using a targeted calcium sensor and live brain imaging, the team watched mitochondria near plaques. Calcium levels there ran high, and nearby neurons were dying. Applying natural amyloid to healthy brain raised mitochondrial calcium too. Blocking the calcium entry channel reduced the overload in their tests. The findings tie plaque protein to a deadly calcium imbalance. That channel becomes a possible drug target.

Catalog record

CREATORCalvo-Rodriguez M, Hou SS, Snyder AC, Kharitonova EK, Russ AN, Das S, Fan Z, Muzikansky A, Garcia-Alloza M, Serrano-Pozo A, Hudry E, Bacskai BJ.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE86 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7195480

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer’s disease By Maria Calvo-Rodriguez, Steven S. Hou, Austin C. Snyder, Elizabeth K. Kharitonova, Alyssa N. Russ, Sudeshna Das, Zhanyun Fan, Alona Muzikansky, Monica Garcia-Alloza, Alberto Serrano-Pozo, Eloise Hudry, Brian J. Bacskai Published in: Nature Communications DOI: 10.1038/s41467-020-16074-2 ABSTRACT Mitochondria contribute to shape intraneuronal Ca2+ signals. Excessive Ca2+ taken up by mitochondria could lead to cell death. Amyloid beta (Aβ) causes cytosolic Ca2+ overload, but the effects of Aβ on mitochondrial Ca2+ levels in Alzheimer’s disease (AD) remain unclear. Using a ratiometric Ca2+ indicator targeted to neuronal mitochondria and intravital multiphoton microscopy, we find increased mitochondrial Ca2+ levels associated with plaque deposition and neuronal death in a transgenic mouse model of cerebral β-amyloidosis. Naturally secreted soluble Aβ applied onto the healthy brain increases Ca2+ concentration in mitochondria, which is prevented by blockage of the mitochondrial calcium uniporter. RNA-sequencing from post-mortem AD human brains shows downregulation in the expression of mitochondrial influx Ca2+ transporter genes, but upregulation in the genes related to mitochondrial Ca2+ efflux pathways, suggesting a counteracting effect to avoid Ca2+ overload. We propose lowering neuronal mitochondrial Ca2+ by inhibiting the mitochondrial Ca2+ uniporter as a novel potential therapeutic target against AD. INTRODUCTION Alzheimer’s disease (AD), the most common age-related neurodegenerative disorder, is characterized by deposition of extracellular senile plaques, neurofibrillary tangles and neurodegeneration, which lead to cognitive impairment and dementia. Despite the extensive efforts to understand its pathophysiology, the exact mechanisms underlying AD remain unknown. The most influential hypothesis for AD postulates that abnormal accumulation of the amyloid β (Aβ) peptide is the precipitating event that triggers a pathogenic cascade of adverse events, and that Aβ oligomers (Aβo), rather than amyloid plaques themselves, are the neurotoxic species of Aβ1 linked to tau aggregation2. Aβ neurotoxicity has also been associated with intraneuronal Ca2+ dyshomeostasis3. The calcium hypothesis of AD4 posits that activation of the amyloidogenic pathway remodels neuronal Ca2+ signaling, altering normal Ca2+ homeostasis and the mechanisms responsible for learning and memory. Previous work from our group and others has shown that Aβ aggregates increase cytosolic Ca2+ levels in vivo both in a mouse model of AD5,6, and after application of soluble Aβo to the brain of naive wild-type (Wt) mice7,8. However, these investigations assessed Ca2+ levels in the cytosol, and whether Aβ affects Ca2+ levels in mitochondria in vivo remains elusive. Mitochondrial malfunction has been proposed as an early event in AD and other aging-related neurodegenerative disorders9. Studies on brains from AD patients and AD mouse models have shown impaired mitochondrial function, manifested as decreased bioenergetics and ATP synthesis10, morphological abnormalities11, imbalance of mitochondrial dynamics12 and redistribution of mitochondria13. Mitochondria participate in intracellular Ca2+ signaling as modulators, buffers and sensors14. After a cytosolic Ca2+ increase, mitochondria rapidly take up Ca2+ to prevent Ca2+ overload into the cytosol. However, excessive Ca2+ taken up into mitochondria, i.e., mitochondrial Ca2+ overload, results in increased reactive oxidative species (ROS) production, ATP synthesis inhibition, mitochondrial permeability transition pore (mPTP) opening, release of cytochrome c, activation of caspases and apoptosis15. In vitro studies have reported that Aβo induce mitochondrial Ca2+ uptake16,17, and Ca2+ transfer from ER to mitochondria18 in cultured rat primary neurons, but whether these findings apply in vivo remains unknown. In the present study, we assess whether Aβ aggregates alter mitochondrial Ca2+ levels in neurons in the mouse brain in vivo. We find elevated Ca2+ levels in neuronal mitochondria in transgenic mice, but only after plaque deposition, and preceding neural death. This mitochondrial Ca2+ overload in vivo involves toxic extracellular Aβ oligomers and requires the mitochondrial Ca2+ uniporter. We propose reducing mitochondrial Ca2+ overload by blocking the mitochondrial Ca2+ uniporter as a novel potential therapeutic target for AD. RESULTS Functional AAV.hSyn.2mtYC3.6 targets neuronal mitochondria We have previously observed cytosolic Ca2+ overload5 and mitochondrial membrane potential decrease11 in the APPswe/PSEN1∆E9 (APP/PS1) Tg mouse after amyloid plaque deposition. Here we hypothesized that Aβ aggregates could also increase neuronal mitochondrial Ca2+ levels in vivo. To study free Ca2+ concentration in mitochondria ([Ca2+]mit) in neurons, we targeted the expression of the ratiometric Ca2+ indicator Yellow Cameleon 3.6 (YC3.6)19 to neuronal mitochondria (Fig. 1a). YC3.6 allows visualization of subcellular Ca2+ concentration based on Förster resonance energy transfer (FRET) imaging between CFP and YFP, quantitatively measuring absolute Ca2+ concentrations. YC3.6 is one of the brightest reporters among the YC versions, and exhibits a large dynamic range and excellent signal-to-noise ratio19. Detailed characterization of hSyn.2mtYC3.6 expression was performed in vitro using neuroblastoma Neuro2a cells (N2a) and mouse primary cortical neurons, and ex vivo after immunofluorescence of sections from a Wt adult mouse brain injected with AAV.hSyn.2mtYC3.6. The punctate and perinuclear pattern expression of 2mtYC3.6 (Fig. 1b, c) suggested its mitochondrial localization. Co-transfection of cells with hSyn.2mtYC3.6 and mRuby-Mito-7 confirmed mitochondrial colocalization of 2mtYC3.6 (Fig. 1b). Co-labeling of AAV.hSyn.2mtYC3.6 with HSP60 antibody (Heat shock protein 60, localized to the mitochondrial matrix) in tissue sections corroborated the mitochondrial and neuronal-specific expression of the 2mtYC3.6 in vivo (Fig. 1c and Supplementary Fig. 1).Fig. 1hSyn.2mtYC3.6 targets neuronal mitochondria and is functional in vivo.a Diagram of construct AAV.hSyn.2mtYC3.6-WPRE. b Mitochondrial counter labeling of 2mtYC3.6 verified proper targeting to mitochondria. N2a cells (top) and primary cortical neurons (bottom) were co-transfected with hSyn.2mtYC3.6 (green) and mRuby-Mito-7 (red) and subjected to confocal microscopy imaging. Scale bar 10 µm. c Colocalization of HSP60 (red) and hSyn.2mtYC3.6 (green) in cortex shown by immunohistochemistry (top). Scale bar 20 µm. Bottom graph shows intensity profile of the ROI across the cell (inset, scale bar 10 µm). Green line represents the intensity of hSyn.2mtYC3.6 and red line represent the intensity of HSP60. d In vitro calibration of 2mtYC3.6. Primary cortical neurons and N2a cells were exposed to varying [Ca2+] solutions, and relative changes in YFP/CFP ratio vs. [Ca2+] are indicated. Left, images are pseudocolored according to the color bar. Scale bar 10 µm. Right, titration curve of 2mtYC3.6 in N2a cells, two independent experiments, number of cells: 0 µM, n = 233; 0.2 µM, n = 339; 0.575 µM, n = 436; 1 µM, n = 332; 2 µM, n = 321; 5.7 µM, n = 356; 10 µM, n = 295; 20 µM, n = 317; 53 µM, n = 372; 100 µM, n = 372; 200 µM, n = 292; 500 µM, n = 209; 1000 µM, n = 274. e Validation of AAV.hSyn.2mtYC3.6 in vivo. Left, multiphoton microscopy imaging of the expression of AAV.hSyn.2mtYC3.6 in the cortex of a C57BL/6 J mouse. Scale bar 20 µm. Middle, pseudocolored images of the mitochondria expressing AAV.hSyn.2mtYC3.6 in basal conditions and after KCl application. Right, recording of the application of KCl to the brain. Gray traces represent single-cell responses and red trace represents averaged (mean ± SEM) [Ca2+]mit responses to 300 mM KCl. Representative of three mice. We calibrated hsyn.2mtYC3.6 in N2a cells. Cells were transfected with hSyn.2mtYC3.6, and 24 h later, cells were permeabilized and exposed to solutions containing increasing known [Ca2+] (Methods). An increase in the YFP/CFP fluorescence ratio of YC3.6 corresponds to an increase in [Ca2+]. Ratios of YFP/CFP fluorescence intensities were plotted against [Ca2+] and fitted with a sigmoidal curve (Fig. 1d). We observed nearly 4-fold increase in the ratio at high [Ca2+]mit (Rmin=0.606, Rmax

Read the complete text